Recall of RENOSKIN

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by Perugia Plastie Company.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2008-04-01
  • Event Country
  • Event Source
    ANSM
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    On 29/03/2008, the company Perugia Plastie Company withdrew from the market the batches of the references contained in the attached message of the medical device called composite matrices for dermal regeneration RENOSKIN, manufactured by Perouse Plastie. This withdrawal follows a few cases reporting difficulties rehydrating the matrix detected during a prospective follow-up on these medical devices. In the event of recent implantation of a device whose hydration would not have been optimal, a risk of slowing or absence of colonization of the matrix could be observed locally and generate a potential risk of localized infection. Perouse Plastie has directly notified the recipients of the incriminated lots with the enclosed message (01/04/2008) (30 ko) validated by Afssaps. This information is addressed to the directors, correspondents of materiovigilance, plastic surgeons and pharmacists responsible for sterile medical devices for dissemination where appropriate to the services concerned. The relevant European Competent Authorities are informed of this measure by the manufacturer.

Device

Manufacturer

  • Source
    LAANSM